XML 21 R9.htm IDEA: XBRL DOCUMENT

Asset Purchase Agreement	3 Months Ended
Sep. 30, 2013
Asset Purchase Agreement
NOTE 4 - ASSET PURCHASE AGREEMENT	On October 10, 2012, the Company executed an asset purchase agreement with Dr. Victor Castano, a related party, whereby the Company issued on September 18, 2013 101,000,000 common shares for the assignment and all rights to Dr. Castano’s patent pending nanotechnology. The Company valued the 101,000,000 shares at par value ($0.001), which resulted in $101,000 of consideration paid for the asset.

Asset Purchase Agreement

3 Months Ended

Sep. 30, 2013

On October 10, 2012, the Company executed an asset purchase agreement with Dr. Victor Castano, a related party, whereby the Company issued on September 18, 2013 101,000,000 common shares for the assignment and all rights to Dr. Castano’s patent pending nanotechnology.

The Company valued the 101,000,000 shares at par value ($0.001), which resulted in $101,000 of consideration paid for the asset.